PAMS
TXMD icon

Pictet Asset Management (Switzerland)’s TherapeuticsMD TXMD Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-236
Closed -$9K – 1807
2021
Q3 		$9K Buy
+236
New +$10.5K ﹤0.01% 1745

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s TXMD Position: Q4 2021 in Review

Pictet Asset Management (Switzerland) sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 236 shares — an estimated $9K sold.

Pictet Asset Management (Switzerland) first reported a position in TXMD in Q3 2021 and held it in 1 quarter. The position peaked at $9K in Q3 2021. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • Pictet Asset Management (Switzerland) reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 236 TherapeuticsMD shares in Q4 2021, an estimated $9K.
  • Pictet Asset Management (Switzerland) first reported a position in TherapeuticsMD in Q3 2021 and held it in 1 quarter.
  • Pictet Asset Management (Switzerland)'s TherapeuticsMD position peaked at $9K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 10 Feb 2022.